Drug Action
Orphenadrine exerts its antiparkinsonian action by reducing the effects of the relative central cholinergic excess that occurs as a result of dopamine deficiency.
PDF page 452
Drug reference
Orphenadrine exerts its antiparkinsonian action by reducing the effects of the relative central cholinergic excess that occurs as a result of dopamine deficiency.
PDF page 452
Parkinsonism | Drug-induced extrapyramidal symptoms (but not tardive dyskinesia) ▶BY MOUTH ▶Adult: Initially 150 mg daily in divided doses, then increased in steps of 50 mg every 2–3 days, adjusted according to response; usual dose 150–300 mg daily in divided doses; maximum 400 mg per day ▶Elderly: Preferably dose at lower end of range
PDF page 452
Acute porphyrias p. 1120. gastro- intestinal obstruction
PDF page 452
Cardiovascular disease. elderly. hypertension. in patients susceptible to angle-closure glaucoma. liable to abuse. prostatic hypertrophy. psychotic disorders. pyrexia
PDF page 452
→Appendix 1: orphenadrine
PDF page 452
▶Common or very common Accommodation disorder. anxiety. dizziness. dry mouth. gastrointestinal disorder. nausea ▶Uncommon Confusion. constipation. coordination abnormal. euphoric mood. hallucination. insomnia. sedation. seizure. tachycardia. urinary retention ▶Rare or very rare Memory loss
PDF page 452
Caution.
PDF page 452
Caution.
PDF page 452
Manufacturer advises caution.
PDF page 452
Use with caution.
PDF page 452
There can be variation in the licensing of different medicines containing the same drug. Forms available from special-order manufacturers include: oral solution Oral solution ▶Orphenadrine hydrochloride (Non-proprietary) Orphenadrine hydrochloride 10 mg per 1 ml Orphenadrine 50mg/5ml oral solution sugar-free | 150 ml P £45.30 DT = £42.76
PDF page 453
Avoid abrupt withdrawal in patients taking long-term treatment.
PDF page 452
Driving and skilled tasks May affect performance of skilled tasks (e.g. driving).
PDF page 452
Initially 150 mg daily in divided doses, then
First-line fragment. Read the complete Indications and Dose section above.
PDF page 452
Preferably dose at lower end of range
First-line fragment. Read the complete Indications and Dose section above.
PDF page 452